Gary W. Cushing

680 total citations
9 papers, 484 citations indexed

About

Gary W. Cushing is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Gary W. Cushing has authored 9 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Surgery and 2 papers in Genetics. Recurrent topics in Gary W. Cushing's work include Growth Hormone and Insulin-like Growth Factors (3 papers), Thyroid Disorders and Treatments (3 papers) and Pituitary Gland Disorders and Treatments (2 papers). Gary W. Cushing is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (3 papers), Thyroid Disorders and Treatments (3 papers) and Pituitary Gland Disorders and Treatments (2 papers). Gary W. Cushing collaborates with scholars based in United States, Brazil and Canada. Gary W. Cushing's co-authors include Sidney H. Ingbar, Donatella Tramontano, Alan C. Moses, Gary Tataronis, Mary G. Amato, Nicholas A. Tritos, John A. Libertino, Gerald J. Heatley, Suzanne M. Slonim and Hani A. Haykal and has published in prestigious journals such as Endocrinology, Thyroid and The American Journal of the Medical Sciences.

In The Last Decade

Gary W. Cushing

9 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary W. Cushing United States 8 362 102 84 73 62 9 484
Matthew M. Goodman United States 14 351 1.0× 198 1.9× 159 1.9× 31 0.4× 66 1.1× 23 675
Giovanna Saraceno Italy 9 298 0.8× 34 0.3× 74 0.9× 36 0.5× 75 1.2× 12 408
Dong‐Lim Kim South Korea 11 406 1.1× 98 1.0× 168 2.0× 26 0.4× 22 0.4× 17 495
G Vaillant France 11 248 0.7× 44 0.4× 137 1.6× 13 0.2× 76 1.2× 27 403
Ryoko Motonaga Japan 11 199 0.5× 163 1.6× 100 1.2× 8 0.1× 46 0.7× 20 354
Jee Hee Yoon South Korea 13 284 0.8× 55 0.5× 118 1.4× 28 0.4× 90 1.5× 64 463
Eulàlia Urgell Spain 12 75 0.2× 109 1.1× 113 1.3× 113 1.5× 46 0.7× 27 465
Shirley Blaichman Canada 7 140 0.4× 77 0.8× 248 3.0× 21 0.3× 14 0.2× 9 429
Lauren R. Teras United States 5 189 0.5× 487 4.8× 111 1.3× 33 0.5× 106 1.7× 8 758
Leilani B Mercado-Asis Philippines 13 408 1.1× 54 0.5× 310 3.7× 14 0.2× 39 0.6× 59 556

Countries citing papers authored by Gary W. Cushing

Since Specialization
Citations

This map shows the geographic impact of Gary W. Cushing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary W. Cushing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary W. Cushing more than expected).

Fields of papers citing papers by Gary W. Cushing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary W. Cushing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary W. Cushing. The network helps show where Gary W. Cushing may publish in the future.

Co-authorship network of co-authors of Gary W. Cushing

This figure shows the co-authorship network connecting the top 25 collaborators of Gary W. Cushing. A scholar is included among the top collaborators of Gary W. Cushing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary W. Cushing. Gary W. Cushing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zonszein, Joel, M. Lombardero, Faramarz Ismail‐Beigi, et al.. (2015). Triglyceride High-Density Lipoprotein Ratios Predict Glycemia-Lowering in Response to Insulin Sensitizing Drugs in Type 2 Diabetes: A Post Hoc Analysis of the BARI 2D. Journal of Diabetes Research. 2015. 1–12. 11 indexed citations
2.
Amato, Mary G., et al.. (2012). Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED) study. Journal of the American Pharmacists Association. 52(5). 613–621. 75 indexed citations
3.
Tritos, Nicholas A., Gary W. Cushing, Gerald J. Heatley, & John A. Libertino. (2000). Clinical Features and Prognostic Factors Associated with Adrenocortical Carcinoma: Lahey Clinic Medical Center Experience. The American Surgeon. 66(1). 73–79. 34 indexed citations
4.
Cushing, Gary W., et al.. (1995). An Association between Acromegaly and Thyroid Carcinoma. Thyroid. 5(1). 47–50. 28 indexed citations
5.
Slonim, Suzanne M., et al.. (1993). MRI appearances of an ectopic pituitary adenoma: case report and review of the literature. Neuroradiology. 35(7). 546–548. 43 indexed citations
6.
Cushing, Gary W.. (1993). Subclinical hypothyroidism. Postgraduate Medicine. 94(1). 95–107. 12 indexed citations
7.
Allen, Elsie M., Rajata Rajatanavin, T Nogimori, et al.. (1986). The Effect of Methimazole on the Development of Spontaneous Lymphocytic Thyroiditis in the Diabetes-Prone BB/W Rat. The American Journal of the Medical Sciences. 292(5). 267–271. 19 indexed citations
8.
Tramontano, Donatella, Gary W. Cushing, Alan C. Moses, & Sidney H. Ingbar. (1986). INSULIN-LIKE GROWTH FACTOR-I STIMULATES THE GROWTH OF RAT THYROID CELLS IN CULTURE AND SYNERGIZES THE STIMULATION OF DNA SYNTHESIS INDUCED BY TSH AND GRAVES′-IgG. Endocrinology. 119(2). 940–942. 257 indexed citations
9.
Cushing, Gary W., et al.. (1978). Amine-catalyzed isomerization of diethylmaleate to diethylfumarate. Journal of Chemical Education. 55(12). 812–812. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026